Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancer Cell|April 5, 2024
Having the cake and eating it? Clofazimine boosts immunotherapy while limiting side effectsLukas Kraehenbuehl, Jedd D Wolchok, Taha Merghoub, et al.
Dermatology (Basel, Switzerland)|April 18, 2026
Comparative Clinical and Histological Analysis of Bullous Pemphigoid: Immunotherapy-Associated vs. Spontaneous Onset CasesThilo Gwerder, Reinhard Dummer, Thomas Kuendig, et al.
Nature Reviews. Clinical Oncology|September 28, 2021
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathwaysLukas Kraehenbuehl, Chien-Huan Weng, Shabnam Eghbali, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 15, 2021
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapyElena Goleva, Taras Lyubchenko, Lukas Kraehenbuehl, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center AnalysisLukas Kraehenbuehl, Stephanie Schneider, Laura Pawlik, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 26, 2026
Incidence, severity and potential pathomechanism of immune-related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapyAndrea Roggo, Nikolina Ivanovic, Patrick Turko, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2021
Immune-related cutaneous adverse events due to checkpoint inhibitorsEvelyn Wang, Lukas Kraehenbuehl, Kwami Ketosugbo, et al.
Cancers|June 24, 2022
Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System InvolvementAlyce M Kuo, Lukas Kraehenbuehl, Stephanie King, et al.
Pageof 3